Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.

Quick Stats
Studies 178
Trials 100
Formula C64H82N18O13
Clear All
Utility 1
pubmed May 13, 2024

Quantitative analysis of therapeutic peptides by CZE using multiple sample injection in hydrodynamically closed separation system.

Stefanik. Ondrej O; Mikus. Peter P; Piestansky. Juraj J

Scientists created a new lab test that can accurately measure tiny amounts of the peptide drug triptorelin (and lanreotide) using a technique called capillary zone electrophoresis. The test works well in water and fake urine, showing good precision and accuracy, and it was proven on a commercial injection powder. However, the method requires specialized equipment and isn’t something most DIY health enthusiasts can use directly.

Utility 1
pubmed Aug 15, 2025

AQbD-based development of a stability-indicating UHPLC-PDA-QDa method for triptorelin in parenteral formulations.

Afonso Urich. Jesús Alberto JA; Marko. Viktoria V; Fedorko. Anna A; Jeremic. Dalibor D

Scientists created a lab test that reliably measures how stable the peptide drug triptorelin is in injectable forms, using a fast chromatography technique. The method checks if the drug breaks down under different stress conditions, but it doesn’t give dosing or performance advice for personal use.

Utility 1
pubmed May 8, 2024

Precocious Puberty and GnRH Analogs: Current Treatment Practices and Perspectives among US Pediatric Endocrinologists.

Breidbart. Emily E; Breidbart. Emily E; Ilkowitz. Jeniece J; Regelmann. Molly O MO; Ashraf. Ambika P...

This study surveyed US pediatric endocrinologists about which GnRH‑like drugs they use for early puberty. Doctors know the short‑acting, monthly or 3‑month shots best, and they often pick the implant or 3‑month shot based on what families want and what insurance will pay. There’s a big price gap between kids’ and adult versions, and doctors aren’t sure when brain scans or lab tests are needed.

Utility 1
pubmed Feb 11, 2025

Efficacy of Triptorelin Combined with Recombinant Human Growth Hormone (rhGH) on Serum Sex Hormones, Bone Age, and Clinical Outcomes in Girls with Precocious Puberty.

Lao. Xiaofei X; Zhao. Lihong L; Zhu. Xiaoqiang X; Yao. Xinmei X; Chen. Huichao H

A study in Chinese girls with early puberty showed that adding growth hormone to the drug triptorelin helped them grow taller and gain more weight, slowed down their bone age, lowered sex hormone levels, and reduced ovarian and uterine size, without serious side effects. This was a pediatric setting, so it doesn’t directly translate to adult self‑experimentation for longevity or performance.

Utility 1
pubmed Sep 29, 2025

Effectiveness and Safety of Postoperative Medical Treatments Following Fertility-Preserving Surgery for Endometriosis: A Network Meta-Analysis.

Xiong. Yi Y; Huang. Wenrui W; Wang. Chenxin C; Ma. Wenjun W; Jin. Sufang S; Lin. Jin J; Deng. Xiaohu...

A large review of medicines taken after endometriosis surgery found that a hormone‑releasing IUD (LNG‑IUS) cuts recurrence and pain the most, while other drugs—including the peptide triptorelin—didn’t show clear benefits and some caused side effects.

Utility 1
pubmed Dec 25, 2024

Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus.

Vaid. Ashok K AK; Pagani. Olivia O; Ramesh. Anita A; Bharthuar. Anubha A; Desai. Chirag C; Biswas. G...

Researchers in India gathered experts to agree on the best way to use hormone‑blocking drugs like triptorelin for premenopausal women with a certain type of early breast cancer. They suggest using the drug to shut down the ovaries, especially in younger women or those at higher risk, and combining it with other cancer medicines for up to five years if it’s tolerated.

Utility 1
pubmed Jun 1, 2025

DiWB-1: A Luteinizing Hormone Releasing Hormone (LHRH)-Targeted Peptide-Drug Conjugate (PDC) With Enhanced Tumor Selectivity and PI3K Inhibition Efficacy.

Zhang. Chenyu C; Zhong. Honglan H; Li. Xiang X; Xing. Zhenjian Z; Li. Siming S; Yu. Rui R; Deng. Xin...

Scientists created a new cancer drug that attaches a targeting peptide to a PI3K inhibitor, making it work better against certain tumor cells while causing fewer side effects in mice, but it’s still early‑stage research and not something you can use yourself yet.

Utility 1
pubmed Jul 13, 2024

Can We Harvest More Mature Oocytes by Repeating Gonadotropin-Releasing Hormone Agonist Doses in Polycystic Ovarian Syndrome Patients at Risk of OHSS in Antagonist Cycles? A Randomised Clinical Trial.

Hashemi. Seyedeh Houra SH; Hafezi. Maryam M; Arabipoor. Arezoo A; Zareei. Maryam M; Vesali. Samira S...

Adding a second small dose of the peptide triptorelin 12 hours after the first dose didn’t give more or better eggs or improve pregnancy results in women with PCOS undergoing IVF, but it did slightly lower the chance of mild to moderate ovarian hyperstimulation syndrome.

Utility 1
pubmed Nov 24, 2023

Role of Inhibin B, AMH, GnRHa Test and HCG Stimulation Test to Distinguish Isolated Hypogonadotropic Hypogonadism (IHH) from Constitutional Delay in Growth and Puberty (CDGP).

Sahoo. Bijay K BK; Kumar. Padala Ravi PR; Pattanaik. Sudhi Ranjan SR; Dash. Deepak Kumar DK; Patro....

The study looked at how well a hormone‑boosting drug called triptorelin can help doctors tell the difference between two reasons why teens might have delayed puberty. It found that measuring LH levels four hours after giving triptorelin perfectly identified a rare condition (IHH), while a blood protein called inhibin B was also useful. Other hormone tests weren’t as helpful.

Utility 1
pubmed Feb 20, 2025

Analyzing estrous cycle dynamics with different protocols of 4.7 mg deslorelin implant aplication in bitches.

Holumbiiovska. Tetiana T; Ochota. Małgorzata M; Prochowska. Sylwia S; Ligocka-Kowalczyk. Zuzan...

The study looked at when to give and take out a hormone implant (deslorelin) to make female dogs go into heat. It found that putting the implant in later after the previous heat (more than 160 days) works better than early, and taking it out around the LH hormone peak gives the most normal cycles and chances of pregnancy. Early timing or leaving the implant in too long messed up hormones and prevented pregnancy.

Utility 1
pubmed 2024

Successful Neoadjuvant Chemotherapy and Surgical Removal of a Nonmetastatic Testicular Round Cell Tumor in a Solomon Island Eclectus Parrot (<i>Eclectus roratus solomonensis</i>).

Baden. Rachel R; Speer. Brian B; Garner. Michael M; Urraca. Vanessa Hern&#xe1;ndez VH; Fitzgerald. B...

A 24‑year‑old male Solomon Island eclectus parrot with a testicular round‑cell tumor was treated with hormone drugs (tamoxifen, leuprolide, deslorelin) and carboplatin chemo before surgery, leading to a 95% shrinkage and successful removal with no recurrence after seven months. This is the first report of such a treatment in a bird, but it doesn’t directly apply to human health‑hacking or typical biohacker goals.

Utility 1
pubmed Feb 1, 2023

Triptorelin Peptide Conjugated Alginate Coated Gold Nanoparticles as A New Contrast Media for Targeted Computed Tomography Imaging of Cancer Cells.

Danesh-Doust. Mohammad M; Irajirad. Rasoul R; Vaziri Nezamdoust. Fereshteh F; Khademi. Sara S; Monta...

Scientists made tiny gold particles coated with a hormone‑like peptide (triptorelin) that stick to certain cancer cells and make them show up brighter on CT scans. In lab tests the particles weren’t toxic to cells and gave up to about three‑times better image contrast than regular agents, but this is still an early‑stage research tool, not a ready‑to‑use product for health‑hacking or personal health protocols.

Utility 1
pubmed Aug 8, 2025

Osteopontin expression in prepubertal and adult dog testes and the effect of slow-release deslorelin implants (Suprelorin&#xae; 4.7 mg).

Liman. Narin N; Balogh. Orsolya O; Fidan. Bet&#xfc;l B; M&#xfc;ller. Linda L; Gram. Aykut A

The study examined a protein called osteopontin (OPN) in dog testes and found it’s much higher in young dogs and in adult dogs that received a GnRH‑agonist implant (deslorelin) that stops sperm production. The drug changed OPN levels, showing that hormonal suppression can affect testicular protein expression.

Utility 1
pubmed Oct 22, 2024

Duration of efficacy and effect of implant location in adult queens treated with a 9.4&#xa0;mg deslorelin subcutaneous implant.

Baldan. A A; Pereira. M M; Pedrotti. V V; Ferro. S S; Gelli. D D; Milani. C C; A. Mollo M; Fontaine....

A study in female cats showed that a 9.4 mg deslorelin implant (a GnRH‑agonist similar to triptorelin) blocks reproduction for about two years, works the same whether placed on the back or near the belly, and is fully reversible with no obvious side effects, though most cats gained weight.

Utility 1
pubmed Aug 22, 2024

Use of a slow-release GnRH implant in an adult billy goat.

Demattio. Lukas L; Fietz. Daniela D; Schuler. Gerhard G; Wehrend. Axel A

A slow‑release GnRH implant (deslorelin) was put into a healthy adult male goat, but after six weeks it didn’t shrink the testicles, didn’t change hormone responses, and sperm production stayed normal, meaning the goat stayed fertile.

Utility 1
pubmed Dec 9, 2023

ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.

Rodriguez-Wallberg. Kenny A KA; Nilsson. Hanna Pauline HP; Bergh. Jonas J; Malmros. Johan J; Ljungma...

This abstract describes a planned clinical trial testing whether the hormone drug triptorelin can protect young women’s fertility during chemotherapy, but it doesn’t provide any results yet, so there’s nothing concrete to act on right now.

Utility 1
pubmed Jun 20, 2023

Case Report: Longitudinal follow-up and testicular sperm extraction in a patient with a pathogenic <i>NR5A1</i> (SF-1) frameshift variant: p.(Phe70Ser<i>fs</i>*5).

Teoli. Jordan J; Mallet. Delphine D; Renault. Lucie L; Gay. Claire-Lise CL; Labrune. Elsa E; Bretone...

A teenage boy with a rare genetic mutation (NR5A1) that affects testicle development was given triptorelin to treat early puberty, but later attempts to collect sperm for future use failed, showing that this drug didn’t improve his fertility prospects.

Utility 1
pubmed Feb 1, 2024

Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.

Loreti. S S; Thiele. K K; De Brucker. M M; Olsen. C C; Centelles-Lodeiro. J J; Bourgain. C C; Waelpu...

This study compared two ways to support the uterine lining after IVF – a pill (oral dydrogesterone) and a vaginal gel (micronized progesterone). It found that both methods gave similar tissue results even though the pill caused higher blood levels of its hormone. The research used a tiny dose of the peptide triptorelin only as part of the egg‑retrieval trigger, not to study its own effects.

Utility 1
pubmed May 1, 2023

Female BMI and Body Weight Is Not Associated with Oocyte Yield and Maturation in hCG, Agonist or Dual Trigger Cycles: A Large Observational Study including 5000 Cycles.

Donno. Valeria V; Garc&#xed;a-Mart&#xed;nez. Sandra S; Polyzos. Nikolaos P NP

A big study looked at whether a woman's body‑mass index (BMI) or weight changes how many eggs are retrieved and how well they mature when using the hormone triggers triptorelin, hCG, or a mix of both. They found no link – heavier or lighter women got the same number and quality of eggs as others, regardless of the trigger used.